Olonyx Eye Drops 0.2% (Olopatadine Hydrochloride) (Single Use)
Olopatadine Hydrochloride
Eye drops · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.
MFDS item code 202501057 · Approved 2025.04.30 · Insurance code 641807431
Relief of symptoms of allergic conjunctivitis
Used to relieve symptoms such as itching, redness, and tearing of the eyes due to allergic conjunctivitis.
1 drop per application, instilled once a day.
This medicine should not be used by patients who are allergic to the active ingredient or any of the excipients. While using this medication, central nervous system adverse reactions such as headaches, taste disturbances, and dizziness may occur. Ocular-related symptoms, such as keratitis, eye pain, dryness, itching, and redness of the eyes, may occur occasionally, and rarely photophobia or blurred vision may also appear. Dryness of the nasal passages or rhinitis symptoms may occur rarely, and symptoms such as dry mouth or dermatitis have been reported. Fatigue may be experienced after using this medication. Additionally, symptoms similar to cold or pharyngitis may appear in about 10% of patients, and fatigue, lumbar pain, and nausea have been reported in some patients. This medicine contains phosphate and may rarely cause calcification of the cornea in cases of severe corneal damage. This medication should not be used in cases of irritation related to wearing contact lenses, and temporary blurring of vision may occur after instillation, so caution is required when driving or operating machinery. During pregnancy, animal studies have shown a possibility of affecting the fetus, so it should be used carefully under medical supervision. During breastfeeding, the drug may be excreted in breast milk, so benefits and risks should be carefully considered before use. It can also be used in children over 3 years of age and the elderly, but caution is needed during use. In case of overdose, patients should be closely monitored and receive appropriate treatment. This medicine should be administered directly into the eyes and care should be taken to avoid having the opening of the container come into contact with the eye area. When using with other eye drops, they should be administered at least 5 minutes apart, and it is safest to use it only once after opening. This medicine is known to have a low risk of carcinogenicity or mutagenicity, but careful use is necessary during pregnancy and breastfeeding.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering, in a cool place at temperatures between 2 to 25 degrees Celsius. Storing it this way can help maintain the efficacy of the medication for a long time.
Colorless to pale yellow transparent solution in a colorless transparent plastic container for eye drops
0.3mL/tube × 10, 12
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride
Eye drops · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.